TraceLink unveils industry’s first Compliance and Digital Information Platform for pharmacies with EU FMD requirements
Application "addresses a critical information gap that has existed for decades between pharmaceutical companies, pharmacists and patients."
TraceLink has unveiled an industry first: an integrated Compliance and Digital Information Platform for pharmacies with EU Falsified Medicines Directive (FMD) requirements.
The new mobile and web-based application enables any pharmacy in the EU to easily comply with verification and decommissioning requirements under the FMD while simultaneously delivering a real-time dashboard for business insights on medicine scans, expiry dates, dispensation trends, product inventory and more. The new platform was revealed at NEXUS 17 in Barcelona during the opening keynote session by TraceLink president and CEO, Shabbir Dahod.
The new Pharmacy Compliance and Digital Information Platform provides a single destination for pharmacies to meet their EU FMD requirements, which take effect in February 2019. Pharmacists who use the application will also benefit from user-friendly dashboard analytics that provide valuable insights from all transaction information that is captured within the application.
Pharmacists can also “opt in” to a service within the app that links them to participating pharmaceutical manufacturers, paving the way for a new digital communication channel designed to enhance the information-sharing between pharmaceutical companies and the healthcare providers who dispense their medications. Once they opt in, pharmacists will be able to receive specific and contextual pharmaceutical product information directly from the manufacturer – including details about indications, usage, best practices for product administration, and potential warnings and precautions - empowering them to deliver a more engaging and informative consultation as they dispense medicines to patients.
“TraceLink has broken new ground with this application, addressing a critical information gap that has existed for decades between pharmaceutical companies, pharmacists and patients,” said Dahod. “Our unique approach of connecting the entire pharmaceutical supply chain on an interoperable network makes TraceLink the only company capable of offering this type of solution and facilitating a new era of real-time information sharing that will transform how the industry provides care to patients. This is the first in a series of steps we are taking to augment our effort of eliminating counterfeit drugs from the global marketplace with applications that deliver tangible and meaningful value to an industry that serves hundreds of millions of people who depend on prescription medications to improve their health.”
TraceLink’s new Pharmacy Compliance and Digital Information Platform merges EU FMD compliance capabilities with real-time insights into pharmaceutical products, offering EU pharmacists the ability to
All services within the Pharmacy Compliance and Digital Information Platform will be provided by TraceLink via its secure Life Sciences Cloud where pharmacists can be assured of the confidentiality and anonymous nature of their dispensing information.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance